Priorities on rare cancers’ policy in National Cancer Control Plans (NCCPs)
By Neuroendocrine Cancer UK
Posted 6 years ago
26/11/202010am
Rare Cancers – results of a study conducted within the EU Joint Action on Rare Cancers: to which degree rare cancers are addressed in national cancer control plans (15 European countries were analysed).
The UK and the Republic of Ireland run the only formal national programme for liver transplantation in patients with neuroendocrine tumours, and evidence shows those transplanted ...
Ongoing variability in the supply of pancreatic enzyme replacement therapy (PERT) — particularly Creon® 25,000iu capsules — has left some people struggling to obtain their prescription. ...